Health Care & Life Sciences » Pharmaceuticals | Cosmo Pharmaceuticals

Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 15.04 M
Public Float
 -
Cosmo Pharmaceuticals N.V.
Stock Exchange SIX Swiss Exchange
EPS
 CHF1.38
Market Cap
 CHF1.46 B
Shares Outstanding
 15.04 M
Public Float
 7.57 M

Profile

Address
Riverside II
Dublin Dublin 2
Ireland
Employees -
Website http://www.cosmopharma.com
Updated 07/08/2019
Cosmo Pharmaceuticals NV engages in the development, manufacturing and distribution of treatments for gastrointestinal diseases, endoscopy, colorectal cancer diagnosis, and colonoscopy. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland. .

Financials

View All
Created with Highcharts 5.0.14Cosmo Pharmaceuticals N.V.Net Income. Fiscal year is January-December. All values CHF Thousands.84 59584 59589 02989 029265 008265 00821 07621 07636 02236 02220 79020 790201320142015201620172018050k100k150k200k250k300k
Created with Highcharts 5.0.14Cosmo Pharmaceuticals N.V.Sales/Revenue. Fiscal year is January-December. All values CHF Thousands.69 37769 37796 64596 64564 71364 71373 73973 73974 65074 65075 75975 759201320142015201620172018025k50k75k100k125k

Hans Christoph Tanner
Executive Director & Head-Transactions Office
Eimar Cowhey
Non-Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.